GORMAN RUPP CO Income Taxes Disclosure
Note 8 – Income Taxes
The components of Income before income taxes are:
|
2024 |
2023 |
2022 |
||||||||||
|
United States |
$ | 38,548 | $ | 34,763 | $ | 6,270 | ||||||
|
Foreign countries |
11,945 | 9,198 | 7,602 | |||||||||
|
Total |
$ | 50,493 | $ | 43,961 | $ | 13,872 | ||||||
The components of income tax expense are:
|
2024 |
2023 |
2022 |
||||||||||
|
Current expense: |
||||||||||||
|
Federal |
$ | 8,223 | $ | 6,735 | $ | 1,581 | ||||||
|
Foreign |
2,121 | 1,591 | 1,264 | |||||||||
|
State and local |
1,451 | 1,098 | 918 | |||||||||
| $ | 11,795 | $ | 9,424 | $ | 3,763 | |||||||
|
Deferred expense (benefit): |
||||||||||||
|
Federal |
$ | (1,476 | ) | $ | (206 | ) | $ | (565 | ) | |||
|
Foreign |
87 | 196 | 147 | |||||||||
|
State and local |
(28 | ) | (404 | ) | (668 | ) | ||||||
| (1,417 | ) | (414 | ) | (1,086 | ) | |||||||
|
Income tax expense |
$ | 10,378 | $ | 9,010 | $ | 2,677 | ||||||
The reconciliation between income tax expense and the amount computed by applying the statutory federal income tax rate to income before income taxes is:
|
2024 |
2023 |
2022 |
||||||||||
|
Income taxes at statutory rate |
$ | 10,603 | $ | 9,232 | $ | 2,913 | ||||||
|
State and local income taxes, net of federal tax benefit |
1,094 | 620 | 282 | |||||||||
|
Tax credits |
(1,608 | ) | (1,208 | ) | (627 | ) | ||||||
|
Uncertain tax positions |
19 | (34 | ) | (99 | ) | |||||||
|
Valuation allowance |
30 | (72 | ) | (85 | ) | |||||||
|
GILTI/FDII |
512 | 368 | 608 | |||||||||
|
Foreign rate differential |
(300 | ) | (145 | ) | (186 | ) | ||||||
|
Other |
28 | 249 | (129 | ) | ||||||||
|
Income tax expense |
$ | 10,378 | $ | 9,010 | $ | 2,677 | ||||||
The Company made income tax payments of $10.2 million, $7.9 million, and $4.5 million in 2024, 2023, and 2022, respectively.
Deferred income tax assets and liabilities consist of:
|
December 31, |
||||||||
|
2024 |
2023 |
|||||||
|
Deferred tax assets: |
||||||||
|
Inventories |
$ | 1,392 | $ | 520 | ||||
|
Accrued liabilities |
3,390 | 3,011 | ||||||
|
Postretirement health benefits obligation |
5,526 | 5,600 | ||||||
|
Pension obligation |
1,351 | 2,386 | ||||||
|
Lease liabilities |
4,861 | 4,916 | ||||||
|
Capitalized R&D |
3,124 | 2,041 | ||||||
|
Interest |
12,884 | 8,703 | ||||||
|
Other |
1,190 | 1,155 | ||||||
|
Total deferred tax assets |
33,718 | 28,332 | ||||||
|
Valuation allowance |
(420 | ) | (390 | ) | ||||
|
Net deferred tax assets |
33,298 | 27,942 | ||||||
|
Deferred tax liabilities |
||||||||
|
Depreciation and amortization |
(27,935 | ) | (22,923 | ) | ||||
|
Leases - right of use assets |
(4,627 | ) | (4,922 | ) | ||||
|
Total deferred tax liabilities |
(32,562 | ) | (27,845 | ) | ||||
|
Net deferred tax assets (liabilities) |
$ | 736 | $ | 97 | ||||
The Company had state tax credit carryforwards of $0.4 million and $0.3 million as of December 31, 2024 and 2023, respectively, which will expire incrementally between 2025 and 2036.
The Company had valuation allowances of $0.4 million at each of December 31, 2024 and 2023, against certain of its deferred tax assets. ASC 740, Income Taxes, requires that a valuation allowance be recorded against deferred tax assets when it is more likely than not that some or all of a Company’s deferred tax assets will not be realized based on available positive and negative evidence.
Total unrecognized tax benefits were $0.7 million at each of December 31, 2024 and 2023. The total amount of unrecognized tax benefits that, if ultimately recognized, would reduce the Company’s annual effective tax rate were $0.6 million at each of December 31, 2024 and 2023. The Company recognizes interest and penalties related to unrecognized tax benefits in income tax expense for all periods presented. The Company accrued approximately $0.2 million for the payment of interest and penalties at each of December 31, 2024, 2023 and 2022.
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
|
2024 |
2023 |
2022 |
||||||||||
|
Balance at beginning of year |
$ | 704 | $ | 754 | $ | 808 | ||||||
|
Additions based on tax positions related to the current year |
217 | 180 | 117 | |||||||||
|
Reductions due to lapse of applicable statute of limitations |
(192 | ) | (230 | ) | (171 | ) | ||||||
|
Balance at end of year |
$ | 729 | $ | 704 | $ | 754 | ||||||
The Company is subject to income taxes in the U.S. federal and various state, local and foreign jurisdictions. Income tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require significant judgment to apply. With few exceptions, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for the years before .
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.